speb/financial-data huggingface dataset:
TECILCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3874000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1029000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -3874000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -3874000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1029000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -101000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -6665000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -6665000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -101000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 34277000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 34277000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 0.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -182483000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -182483000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: -3634000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -970000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Normalized Income: -3874000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -1029000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 6638000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Operating Income: -3875000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: -1030000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 18963700.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 18963700.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 100000000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 100000000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 16480000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 16480000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 43726000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 43726000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 2167000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 563000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 358000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 358000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 34278000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 34278000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 9263000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 9263000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 78000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 78000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Payables: 515000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 515000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 9263000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 9263000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Pretax Income: -3874000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -1029000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 0.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: 0.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1145000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 295000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 240000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 60000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -584569000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -584569000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 0.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 323000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 112000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 18963700.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 18963700.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: 0.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: -182483000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -182483000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: -182483000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -182483000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 102000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 102000.00
TECILCHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 43727000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 43727000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: -56788000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -56788000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 125695000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 125695000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: -182483000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -182483000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 3875000.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1030000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 226210000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 226210000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 34282000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 34282000.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 125695000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 125695000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 1000.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
TECILCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TECILCHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: -91071000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -91071000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 489000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 19550000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.04
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 293000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 19550000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.04
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 17000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: -293000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 415000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 293000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 17000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 782000.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 802000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 230000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 5000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 18216667.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.06
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 189637000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 214000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 189637000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -184426000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 291000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 10071000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 100258000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 18216667.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.06
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — EBIT: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: -1036000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 108000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 34096000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: -291000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: -56086000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 5000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 128340000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 128340000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 128339000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1093000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 34096000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -184426000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1036000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 18963700.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 100028000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -374063000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 44172000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 637000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 34096000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 9755000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 213000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 230000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -1093000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 291000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 108000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 18963700.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -184426000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -184426000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 102000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 44172000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -56086000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 128340000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -184426000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 1093000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 228598000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 34101000.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 128340000.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -90187000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 439000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 18125000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.04
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 285000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 18125000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.04
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: -724000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: -667000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 20000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: -285000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -667000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: -724000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 362000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -725000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 285000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 57000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 20000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 724000.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 3096000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1365000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 23000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 23000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 5000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 5000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 18288889.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.09
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 79000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 189637000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 189637000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 59000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 59000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 0.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 387000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: -134000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 42000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 295000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -20000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 189637000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 189637000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: -186728000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -186728000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 1152000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 282000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 10071000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 10071000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 100768000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 100768000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 367000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 367000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 367000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 195000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 367000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 195000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 18288889.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.09
TECILCHEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1646000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — EBIT: -4248000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — EBIT: -1647000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — EBITDA: -3881000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: -1452000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 59000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 3565000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -3585000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 291000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 146000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 33912000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 33912000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Gross Profit: -1152000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: -282000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: -57468000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: -57468000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 5000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 5000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 129260000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 129260000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 129260000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 129260000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 129260000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 129260000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Net Income: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income: -1646000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1646000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1646000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1646000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1646000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -4247000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1646000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 0.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 3565000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 3565000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 33912000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 33912000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 0.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -186728000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -186728000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: -3881000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -1452000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Normalized Income: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -1646000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -3585000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Operating Income: -4248000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: -1647000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 18963770.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 18963770.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 700000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 700000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 100363000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 100363000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: -376365000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -376365000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 1000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2438000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1024000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 33912000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 33912000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 9210000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 9210000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 59000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 59000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Payables: 23000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 23000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Pretax Income: -4247000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -1646000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 0.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1152000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 282000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 367000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 195000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: 0.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 0.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 291000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 146000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 18963770.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 18963770.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: -186728000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -186728000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: -186728000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -186728000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Tax Provision: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 102000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 102000.00
TECILCHEM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 43300000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 43300000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: -57468000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -57468000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 129260000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 129260000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: -186728000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -186728000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Total Expenses: 4248000.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1647000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 230028000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 230028000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 33917000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 33917000.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 129260000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 129260000.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
TECILCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TECILCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TECILCHEM.NS balance_sheet (annual, 2026-03-31) — Working Capital: -90697000.00
TECILCHEM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: -90697000.00
TECK balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
TECK balance_sheet (annual, 2021-12-31) — Cash Equivalents: 790000000.00
TECK balance_sheet (annual, 2021-12-31) — Cash Financial: 637000000.00
TECK balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 30000000.00
TECK balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 30000000.00
TECK cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -4000000.00
TECK balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 1000000.00
TECK cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -80000000.00
TECK cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -335000000.00
TECK cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
TECK income_statement (annual, 2021-12-31) — Other Special Charges: 168000000.00
TECK balance_sheet (annual, 2021-12-31) — Prepaid Assets: 299000000.00
TECK income_statement (annual, 2022-12-31) — +Operating Expense: 1383000000.00
TECK income_statement (annual, 2022-12-31) — +Total Revenue: 17316000000.00
TECK balance_sheet (annual, 2022-12-31) — Accounts Payable: 1897000000.00
TECK balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1527000000.00
TECK balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -22640000000.00
TECK balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 207000000.00
TECK cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
TECK balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 1566000000.00
TECK balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 364000000.00
TECK income_statement (annual, 2022-12-31) — Basic Average Shares: 526700000.00
TECK income_statement (annual, 2022-12-31) — Basic EPS: 6.30
TECK cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1427000000.00
TECK cash_flow (annual, 2022-12-31) — Capital Expenditure: -5465000000.00
TECK cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -5465000000.00
TECK balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 571000000.00
TECK balance_sheet (annual, 2022-12-31) — Capital Stock: 6139000000.00
TECK balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1883000000.00
TECK balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1883000000.00
TECK cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -532000000.00
TECK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -1959000000.00
TECK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -5551000000.00
TECK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 7541000000.00
TECK cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: -31000000.00
TECK cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: -129000000.00
TECK cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 442000000.00
TECK cash_flow (annual, 2022-12-31) — Change In Account Payable: 237000000.00
TECK cash_flow (annual, 2022-12-31) — Change In Inventory: -421000000.00
TECK cash_flow (annual, 2022-12-31) — Change In Payable: 237000000.00
TECK cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 237000000.00
TECK cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -401000000.00
TECK cash_flow (annual, 2022-12-31) — Change In Receivables: 478000000.00
TECK cash_flow (annual, 2022-12-31) — Change In Working Capital: -107000000.00
TECK cash_flow (annual, 2022-12-31) — Changes In Cash: 313000000.00
TECK balance_sheet (annual, 2022-12-31) — Common Stock: 6139000000.00
TECK cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -532000000.00
TECK balance_sheet (annual, 2022-12-31) — Common Stock Equity: 25473000000.00
TECK cash_flow (annual, 2022-12-31) — Common Stock Issuance: 234000000.00
TECK cash_flow (annual, 2022-12-31) — Common Stock Payments: -1392000000.00
TECK balance_sheet (annual, 2022-12-31) — Construction In Progress: 14313000000.00
TECK income_statement (annual, 2022-12-31) — Cost Of Revenue: 8745000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1252000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Assets: 8293000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 132000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Debt: 616000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 748000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 19000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 19000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Liabilities: 5864000000.00
TECK balance_sheet (annual, 2022-12-31) — Current Provisions: 361000000.00
TECK cash_flow (annual, 2022-12-31) — Deferred Income Tax: 2495000000.00
TECK cash_flow (annual, 2022-12-31) — Deferred Tax: 2495000000.00
TECK balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 224000000.00
TECK cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1674000000.00
TECK cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1674000000.00
TECK balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 26000000.00
TECK income_statement (annual, 2022-12-31) — Diluted Average Shares: 535900000.00
TECK income_statement (annual, 2022-12-31) — Diluted EPS: 6.19
TECK income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 3317000000.00
TECK income_statement (annual, 2022-12-31) — EBIT: 6545000000.00
TECK income_statement (annual, 2022-12-31) — EBITDA: 8219000000.00
TECK income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 4000000.00
TECK cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 178000000.00
TECK balance_sheet (annual, 2022-12-31) — Employee Benefits: 420000000.00
TECK cash_flow (annual, 2022-12-31) — End Cash Position: 1883000000.00
TECK balance_sheet (annual, 2022-12-31) — Financial Assets: 56000000.00
TECK cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1990000000.00
TECK cash_flow (annual, 2022-12-31) — Free Cash Flow: 2518000000.00
TECK income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: -4000000.00
TECK income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -272000000.00
TECK balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1062000000.00
TECK income_statement (annual, 2022-12-31) — General And Administrative Expense: 472000000.00
TECK balance_sheet (annual, 2022-12-31) — Goodwill: 1118000000.00
TECK balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1518000000.00
TECK balance_sheet (annual, 2022-12-31) — Gross PPE: 62735000000.00
TECK income_statement (annual, 2022-12-31) — Gross Profit: 8571000000.00
TECK income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
TECK balance_sheet (annual, 2022-12-31) — Income Tax Payable: 104000000.00
TECK income_statement (annual, 2022-12-31) — Interest Expense: -20000000.00
TECK income_statement (annual, 2022-12-31) — Interest Expense Non Operating: -20000000.00
TECK income_statement (annual, 2022-12-31) — Interest Income: 4000000.00
TECK income_statement (annual, 2022-12-31) — Interest Income Non Operating: 4000000.00
TECK cash_flow (annual, 2022-12-31) — Interest Paid Cff: -459000000.00
TECK balance_sheet (annual, 2022-12-31) — Interest Payable: 100000000.00
TECK balance_sheet (annual, 2022-12-31) — Inventory: 2685000000.00
TECK balance_sheet (annual, 2022-12-31) — Invested Capital: 34919000000.00
TECK cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5680000000.00
TECK balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 364000000.00
TECK balance_sheet (annual, 2022-12-31) — Investments And Advances: 1503000000.00
TECK balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 0.00
TECK balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 1139000000.00
TECK cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 234000000.00
TECK cash_flow (annual, 2022-12-31) — Issuance Of Debt: 569000000.00
TECK balance_sheet (annual, 2022-12-31) — Land And Improvements: 18567000000.00
TECK balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 439000000.00
TECK balance_sheet (annual, 2022-12-31) — Long Term Debt: 8830000000.00
TECK balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 9269000000.00
TECK cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 569000000.00
TECK cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1461000000.00
TECK balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1139000000.00
TECK balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2805000000.00
TECK balance_sheet (annual, 2022-12-31) — Minority Interest: 1038000000.00